The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the toxicity and outcomes of the combination of midostaurin and CLAG-M in patients with FLT3-mutated acute myeloid leukemia (AML): A multi-center retrospective analysis.
 
Ashley Wen Chen
No Relationships to Disclose
 
Grace Tonghwa Baek
No Relationships to Disclose
 
Shannon Palmer
No Relationships to Disclose
 
Jack Rasmussen
No Relationships to Disclose
 
Joseph S. Bubalo
Research Funding - Angiocrine Bioscience
 
Swathi Namburi
Honoraria - Medscape
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene/Juno; Bristol-Myers Squibb/Celgene/Juno (Inst); Janssen; ORIC Pharmaceuticals (Inst); Regeneron (Inst); Sanofi
 
Tenley Schwarz
No Relationships to Disclose
 
Tenzin Tsomo
No Relationships to Disclose
 
Jonathan Cohen
Employment - SERVIER
 
Kathryn Russell
No Relationships to Disclose
 
Carole Shaw
No Relationships to Disclose
 
Megan Othus
Consulting or Advisory Role - Biosight; Cascadia Labs; Daiichi Sankyo; Glycomimetics; Merck
Other Relationship - Celgene; Glycomimetics; Grifols
 
Anna B. Halpern
Consulting or Advisory Role - Abbvie; Agios; Notable labs
Research Funding - Bayer (Inst); disc medicine (Inst); Gilead/Forty Seven (Inst); Imago Pharma (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst)